TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/24 16:04 | 5/10/24 | XERS | Xeris Biopharma Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Schmid John P. | IL | D | P | 10 | 1.91 | 0 | 5 | 7 | 80 | I | ||||||||||||||||
3/25/24 19:10 | 3/22/24 | DSGN | Design Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schmid John P. | CA | D | P.m | 100 | 3.70 | 0 | 27 | 88 | 58 | I | |||||||||||||||
3/14/24 21:03 | 3/14/24 | XERS | Xeris Biopharma Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Schmid John P. | IL | D | P | 10 | 2.16 | 0 | 5 | 6 | 74 | I | ||||||||||||||||
11/17/23 18:35 | 11/16/23 | XERS | Xeris Biopharma Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Schmid John P. | IL | D | P | 10 | 1.51 | 0 | 7 | 10 | 70 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |